Skip to main content
Caplight Logo









Quibim

Quibim

Private
ValenciaHealthcare & Life Scienceshttps://quibim.com/

Last Round

Series A

Jan 28, 2025

Total Funding Raised

$61.71M

Company Overview

Quibim is a health technology company that develops artificial intelligence-powered solutions for medical imaging analysis to extract quantitative biomarkers for diagnostics and drug development.

Sector

Healthcare & Life Sciences

Verticals

Medical Imaging, Medical AI, Healthcare Analytics, Clinical Trials, Computer Vision

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting, Usage-Based SaaS

AI Layer

Application

Keywords

medical imagingradiology AIAI diagnosticsimaging biomarkersclinical decision supportmedical AImedtechhealthcare analyticsclinical trialscomputer visionradiomicsautomated segmentationSaaSPACS integrationdigital pathology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Quibim Comparables

Compare Quibim with similar companies based on industry and business-model similarity.

Quibim comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Qure.ai
82%
Brainomix
81%
Cortechs.ai
80%

Quibim Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJan 28, 2025
SeedJul 21, 2020
GrantDec 1, 2018
GrantFeb 1, 2018

Quibim Investors

Notable investors and investment history

Quibim investors
InvestorRounds
Asabys PartnersSeries A
Amadeus Capital PartnersSeries A, Seed
PartechSeed, Series A
PartechSeries A
LeadwindSeries A
GED CapitalSeries A
Build CollectiveSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 12, 2026

    Grew 19% QoQ, from 93 to 111 employees.

  • Jun 26, 2025

    Launched AI-QUAL for automated prostate MRI image quality assessment.

Quibim Filings

Explore SEC and related filing metadata, where available.

Quibim filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Quibim's valuation, stock price, and market status.

Is Quibim a public or private company?

Quibim is a private company.

What is the current stock price of Quibim?

Quibim is a private company with no public stock price. No recent secondary market data is available.

How much is Quibim worth (valuation)?

Valuation information for Quibim is not publicly available.

Can I buy Quibim stock?

Quibim shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Quibim's last funding round?

Quibim's most recent funding round was Series A on January 28, 2025.

Who are the main investors in Quibim?

Key investors in Quibim include Asabys Partners, Amadeus Capital Partners, GED Capital, Buenavista Equity Partners, Adara Ventures.

Will Quibim IPO soon?

No public IPO plans have been announced for Quibim.

How can I track Quibim secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Quibim's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersValencia
Employee Range109
Year Founded2012
Last FundingJan 28, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?